EFFICACY OF SYSTEMIC ENZYMES IN SERRAQUIN ES15
IN TREATING NON-SPECIFIC CASES OF
LAMENESS AMONG EQUINES (In Brief)
Dr. Rakesh Pattu, BVSc & AH Study on File 9/20/2005
1) A trial was conducted on six race horses suffering from non-specific lameness. The goal of the
study was to test the efficacy of the ingredients in Serraquin ES15 in ameliorating their condition.
SERRAQUIN ES15 is FORMULATED FOR Steel Horse Formulations LLC
2) All six clinically lame horses have been examined and the seat of lameness identified. All
horses were given the ingredients in Serraquin ES15 powder at 10 grams orally three times daily for a period of 7 days.
No other analgesic, anti-inflammatory or moist dressings were used.
3) Five out of six horses showed complete recovery and one horse continued to show lameness.
The results are as follows:
Number Name Diagnosis Remarks
1 Flying Hawk Tendinitis LF Responded
2 Heart Throb Sprain Ligament Knee LF No Response
3 Power On Sprain Ligament Lumbar Region Responded
4 Answer Sprain Muscle Should LF Responded
5 Montgomery Hero Tendinitis RF Responded
6 Picardo Sprain Ligament Stifle RH Responded
4) Hematological, urine and fecal examination was carried out during pre and post trial period. No
significant hematological, urine or fecal parameter changes were noted.
Since the results are quite encouraging, a comparative study on a larger number of animals to
further determine its efficacy on bone, tendon, ligament and muscle related conditions.
Efficacy of the ingredients in Serraquin ES15 in Equine Lameness, An Observation (Abstract)
Study on File 4/18/2006
Dr. Surajit Basu BVSC & AH
In a study of a 16 year old gelding and a 7 year old mare, both presenting with lameness, the
combination of proteolytic enzymes in Serraquin ES15 demonstrated effectiveness in reducing pain &
inflammation. In addition, the product demonstrates fibrinolytic activity and improves microcirculation to the affected areas.
Full Study Available Upon Request.